Humacyte, Inc. (HUMA) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $113.26M | -40.6% |
| 2024 | $190.54M | +66.2% |
| 2023 | $114.68M | +31.2% |
| 2022 | $87.37M | -46.8% |
| 2021 | $164.36M | +356.3% |
| 2020 | $36.02M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $113.26M | -40.6% |
| 2024 | $190.54M | +66.2% |
| 2023 | $114.68M | +31.2% |
| 2022 | $87.37M | -46.8% |
| 2021 | $164.36M | +356.3% |
| 2020 | $36.02M | — |